Mid-term efficacy of the Cartiva synthetic cartilage implant in symptomatic hallux rigidus.
William R FletcherThomas CollinsAnna FoxAnand PillaiPublished in: Bone & joint open (2024)
This study represents the longest-term independent follow-up in the literature. It shows reassuring mid-term efficacy of the Cartiva SCI with better-than-expected survival. However, deterioration in scores for a subset of patients and lower satisfaction may predict ongoing failure in this group of patients. Additionally, males were noted to have a lower degree of improvement in scores than females. As such, ongoing observation of the SCI to assess durability and survivability, and identify predictive factors, is key to improving patient selection.